UNIVERSITY HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $9.2M
- Transactions
- 1,904
- Companies
- 40
- Average per transaction
- $4,841
Who reported the payments
| Novartis | $1,229,930 |
| Alkermes, Inc. | $1,051,625 |
| Takeda Pharmaceuticals U.S.A., Inc. | $780,660 |
| Merck | $585,919 |
| E.r. Squibb & Sons, L.L.C. | $419,754 |
| Intuitive Surgical | $377,366 |
| Diagnostica Stago, Inc | $329,606 |
| AbbVie | $247,636 |
| Janssen Scientific Affairs, LLC | $245,000 |
| AstraZeneca | $221,760 |
| Sanofi Pasteur Inc. | $194,000 |
| Pfizer | $182,203 |
| BONE Support AB | $154,975 |
| Clovis Oncology, Inc. | $127,000 |
| Medtronic | $125,659 |
| Madrigal Pharmaceuticals | $111,540 |
| Transmedics, Inc. | $102,554 |
| Johnson & Johnson | $95,500 |
| Tersera Therapeutics LLC | $91,116 |
| Novo Nordisk | $86,400 |
| Jazz Pharmaceuticals Inc. | $84,750 |
| Regeneron Healthcare Solutions, Inc. | $78,250 |
| Aesculap Biologics, LLC | $72,867 |
| Medical Device Business Services, Inc. | $70,106 |
| Amgen | $68,835 |
| Gilead | $64,700 |
| Davol Inc. | $62,364 |
| H. Lundbeck A S | $59,133 |
| National Marrow Donor Program | $57,560 |
| Biomarin Pharmaceutical Inc. | $56,235 |
| Pacira Therapeutics, Inc. | $51,999 |
| Stryker | $50,586 |
| GW Research Limited | $47,981 |
| Artivion, Inc. | $46,670 |
| Ormco Corporation | $46,444 |
| Genentech USA, Inc. | $43,750 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $42,050 |
| Varian Medical Systems, Inc. | $40,000 |
| Abbott | $37,430 |
| Incyte Corporation | $37,211 |